President Barack Obama nominated Donald Berwick to head the Centers for Medicare and Medicaid Services, the first confirmed leader in this role since 2006. Berwick has been an outspoken critic of waste and inefficiency.
If the main objective of health reform is to lower expenditures while expanding access and improving quality of care, Donald Berwick is well-suited to play a lead role in the effort.
Despite its importance, CMS has not had a confirmed leader since 2006, when Mark McClellan left the job after establishing the Medicare drug benefit. Democrats stymied confirmation of the next Bush administration nominee, Kerry Weems, and Obama delayed naming someone to the job last year for fear it would detract from health reform legislation.
Yet, the new CMS chief also raised a lot of eyebrows by voicing admiration for the British national health system and by acknowledging that efforts to reduce healthcare spending will involve some kind of rationing and cost controls. He is a fan of managed care in principle, but highly critical of MCOs that he says just "manage money" and don't provide quality care.
Republicans seized these comments, calling them evidence that the real intent of "Obamacare" is to establish a government-run system. Critics also noted that Berwick has little experience running large organizations like CMS, with its annual budget of $800 billion.
Even so, Berwick has full authority over CMS for a limited tenure, during which he will be positioned to defend administration reforms. As a recess appointee, though, his term will end when Congress adjourns in late 2011, unless renominated by the White House.
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
Inflation Reduction Act: Reforms to Patient Cost-Sharing
September 18th 2023Lower out-of-pocket costs for patients might put upward pressure on drug prices, as manufacturers face less price sensitivity, note Matthew Majewski and Rhett Johnson of Charles River Associates. But they also note that upward pressure on price is likely to be limited to the inflation rate as any additional price increase would need to be paid back to CMS in the form of inflation rebates.
Read More
Spending climbed by 2.7% in 2021. In 2020, it soared by 10.3%, fueled by federal government spending in response to the pandemic. The blizzard of calculations of 2021 healthcare spending by CMS’ actuaries also provides further evidence that utilization of healthcare services bounced back in 2021.
Read More